| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6192794 | Journal of Thoracic Oncology | 2015 | 8 Pages |
Abstract
In patients with operable esophageal squamous cell carcinoma, perioperative regimen of PCF can significantly improve 5-year relapse-free and overall survival comparing with preoperative chemotherapy alone. (The trial has been registered at ClinicalTrials.gov, number NCT01225523.)
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yang MD, ZhiJun PhD, WeiLi MD, Xin PhD, HuaFeng MD, YunFeng MD, Hong MD, PhD, Xi Jing MD,